GE HealthCare and Mayo Clinic have launched a new radiation therapy initiative called GEMINI-RT. This collaboration builds on their 2023 radiology research partnership, combining Mayo Clinic’s clinical and research expertise with GE’s technical and engineering capabilities to advance prediction, planning, automation, workflow, and monitoring in radiation oncology.
The GEMINI-RT initiative aims to integrate imaging, advanced therapies, dosimetry, and patient monitoring throughout the patient journey to provide more comprehensive and personalized cancer care. It seeks to make personalized treatments more accessible by streamlining data-driven approaches, focusing on four strategic areas: automation, predictive oncology, multi-modal therapies, and connected care.
The partnership will develop AI-enabled tools to eliminate repetitive tasks and accelerate treatment planning. Clinical insights will be utilized to personalize cancer treatment decisions, improving patient outcomes. The initiative will also explore combining radiation with emerging treatments such as targeted drugs and precision heating. Additionally, AI, biomarkers, and sensors will be used to monitor patients beyond the clinic, aiming to predict side effects early and support home-based care.
Research activities for GEMINI-RT will take place at Mayo Clinic’s Rochester, Minnesota campus. The initiative builds on the 2023 strategic radiology research alliance between the two organizations, which focuses on innovations in MRI, theranostics, and diagnostic and interventional ultrasound.
Radiation therapy is a critical treatment used in over half of oncology cases globally, including more than 2 million patients annually in the United States. GE HealthCare recently acquired Intelerad for $2.3 billion, reinforcing its commitment to AI-powered, cloud-based precision medicine and oncology solutions. Mayo Clinic continues to advance personalized treatments through the use of AI and real-world data.
Dr. Bryan Traughber, vice chair of innovation for radiation oncology at Mayo Clinic, said, “GEMINI-RT is grounded in the concept of ‘twinning the patient, personalizing the beam.’ The combination of research and technological acumen could allow us to model individual patient journeys with precision, enabling radiation therapy treatments that are truly tailored to each patient.”
Dr. Ben Newton, GE HealthCare’s global head of oncology, added, “This effort enables us to collaborate on solutions that are not only leading-edge but also clinically meaningful, helping shape the future of personalized radiation therapy. By integrating innovative technology and AI across the care continuum, we can improve clinician experience, support high-quality patient care, and help reduce burnout among care teams.”
Leave a Reply